Page last updated: 2024-09-03

blonanserin and carbostyril

blonanserin has been researched along with carbostyril in 2 studies

Compound Research Comparison

Studies
(blonanserin)
Trials
(blonanserin)
Recent Studies (post-2010)
(blonanserin)
Studies
(carbostyril)
Trials
(carbostyril)
Recent Studies (post-2010) (carbostyril)
121219312,8551,3235,611

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishitobi, M; Kosaka, H; Murata, T; Shukunami, K; Wada, Y1
Kanno-Nozaki, K; Katsumi, A; Mashiko, H; Miura, I; Niwa, S; Shiga, T; Yabe, H1

Trials

1 trial(s) available for blonanserin and carbostyril

ArticleYear
Switching antipsychotics to aripiprazole or blonanserin and plasma monoamine metabolites levels in patients with schizophrenia.
    Human psychopharmacology, 2014, Volume: 29, Issue:2

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Chromatography, High Pressure Liquid; Female; Homovanillic Acid; Humans; Japan; Male; Methoxyhydroxyphenylglycol; Middle Aged; Piperazines; Piperidines; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Time Factors; Treatment Outcome

2014

Other Studies

1 other study(ies) available for blonanserin and carbostyril

ArticleYear
Adjunctive treatment with low-dosage aripiprazole for blonanserin-induced hyperprolactinemia in a female patient with schizophrenia.
    Progress in neuro-psychopharmacology & biological psychiatry, 2010, Oct-01, Volume: 34, Issue:7

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Dopamine Antagonists; Female; Humans; Hyperprolactinemia; Piperazines; Piperidines; Quinolones; Schizophrenia

2010